Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 29, 2025

Rover Further Expands into Europe
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Rover, a leading online marketplace for loving pet care, today announced it has launched in Denmark and Ireland, bringing its trusted services to millions of new pet parents. The expansion into two new countries …

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases
CAMBRIDGE, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that it will present three related posters at the upcoming 2025 Digestive Disease Week (DDW) Conference …

Perspective Therapeutics Announces First Patient Dosed with PSV359 in a Phase 1/2a Study in Patients with FAP-α Positive Solid Tumors
SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, announced today that the first …

Denodo Platform 9.2 Delivers Intuitive Data Marketplace Experience Supported by Advanced Generative AI (GenAI) Capabilities
PALO ALTO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced the launch of Denodo Platform 9.2, adding new intuitive functionality to Denodo Platform 9.1, released in November, 2024, that builds on the Denodo …

Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation OXFORD, UK and CLEVELAND, Ohio, US, 29 April 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and …

Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference
MENLO PARK, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including …

Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific …

Skye Bioscience to Participate in May Investment and Medical Conferences
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will …

Regeneron Reports First Quarter 2025 Financial and Operating Results
First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22 First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 billion versus first quarter 2024 First quarter 2025 EYLEA …

AgEagle Aerial Systems Receives Non-Compliance Notice from NYSE American and Makes NYSE American Section 610(b) Public Announcement
WICHITA, Kan., April 29, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS) a leading provider of best-in-class unmanned aerial systems (UAS), sensors and software solutions for customers worldwide in the commercial and government verticals, …

Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
LOUISVILLE, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarter ended March 31, 2025 after the close of trading on …

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- ZEVASKYN fills a critical need for people living with RDEB, a debilitating dermatological condition with no cure - - Approval based on the pivotal Phase 3 VIITAL™ study, showing ZEVASKYN resulted in significant wound healing and pain reduction after a …

Serina Therapeutics to Present at JonesResearch Virtual CNS Day
HUNTSVILLE, AL, April 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 Q1 2025 revenue exceeds operating expenses excluding non-cash charges Conference call today at 9:00 a. …

Ambow Launches HybriU Conferencing: A Next-Gen Platform for Smart, Seamless Phygital (Physical + Digital) Collaboration
Cupertino, Calif, April 29, 2025 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. (NYSE American: AMBO) (“Ambow” or the “Company”), a leading global EdTech and AI-powered solutions provider, today announced the official launch of HybriU Conferencing, a …

Comment l’IA peut impacter l’industrie des télécoms
Une chose est désormais évidente, l’intelligence artificielle est aujourd’hui une technologie de rupture qui amène l’ensemble des secteurs d’activités et tous les métiers à évoluer et à intégrer de nouvelles possibilités. Dans ce contexte, le secteur des …

Provectio annonce la nomination du Responsable de son offre Cybersécurité
Provectio fait évoluer son équipe en annonçant la promotion de Mounir AIT BAHADDA au poste de Responsable de son département Cybersécurité. Positionnée au centre de sa stratégie de croissance, la Cybersécurité pour les TPE et PME bretonnes est une activité …

Behind DHgate’s U.S. #2 Milestone: SendCloud Powers Email Engagement as Aurora Mobile & EngageLab Drive Ecosystem Growth
SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- EngageLab’s parent company, Aurora Mobile (NASDAQ: JG), is proud to announce its subsidiary, SendCloud, provided seamless customer communication for DHgate during its recent unprecedented user surge in the U.S. …

Open Invention Network Turns 20
DURHAM, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Open Invention Network (OIN), the only institution focused on mitigating patent risk in open source software, is marking its 20th year of protecting Linux and open source technologies from patent aggressors. …

Aurora Mobile’s SendCloud Partners with DHgate to Power Seamless Customer Communication
SHENZHEN, China, April 29, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary Wuhan …